Meningitis Research Foundation welcomes live-saving vaccines

Meningitis Research Foundation welcomes live-saving vaccines

21 June 2015

UK based international charity Meningitis Research Foundation (MRF) welcomes the launch of two new immunisation programmes in England and Scotland which will save lives from meningococcal meningitis and septicaemia.

In September, vaccination for babies against meningococcal group B (MenB) will be introduced into the country’s routine immunisation programme for children and from August, 17 and 18 year olds will be offered a one off vaccine against meningococcal groups ACWY (MenACWY).

Natalie died from the group B strain of Meningococcal Meningitis, a bacterial form of meningitis

There are three forms of meningitis, bacterial, viral and fungal.

Bacterial meningitis is very serious and can be fatal without urgent treatment with antibiotics. There are five main groups A, B, C, W135 and Y.  
Groups A and Y are extremely rare in the UK; there are a small number of cases of W135; group C is more common but largely controlled by the vaccination programme; B is the most common and currently there is no vaccine for it available.

Viral meningitis
is a more common form than bacterial meningitis and although can make people very ill it is rarely life threatening.

Fungal meningitis is extremely rare and usually affects people with severely weakened immune systems.

There are a number of symptoms of meningitis that present themselves in varying degrees and sometimes not at all.  Early diagnosis and treatment is vital.

For detailed information plus help lines and support please use web-links below.

Meningitis Research Foundation

The Meningitis Trust